Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review
Polycystic Ovary Syndrome (PCOS) is characterized by hyperandrogenism, amenorrhea, and polycystic ovaries. This endocrinopathy is associated with many metabolic disorders such as dyslipidemia and insulin resistance, with increased risk of type 2 diabetes mellitus, metabolic syndrome, and cardiovascu...
Guardado en:
Autores principales: | Carvalho Laura M. L., dos Reis Fernando M., Candido Ana Lucia, Nunes Fernanda F. C., Ferreira Claudia N., Gomes Karina B. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fe98eb016ac4a9b9e9d18949be2b9d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
por: Congcong Jin, et al.
Publicado: (2021) -
The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study
por: Hanxiao Chen, et al.
Publicado: (2021) -
Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome
por: Jialyu Huang, et al.
Publicado: (2021) -
MODERN CONCEPTS OF THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (LITERATURE REVIEW)
por: O. V. Panarina, et al.
Publicado: (2017) -
Association Between Menstrual Patterns and Adverse Pregnancy Outcomes in Patients With Polycystic Ovary Syndrome
por: Ting Yu, et al.
Publicado: (2021)